Summary

Transplant Diagnostics Market – Scope of Report
TMR’s report on the global transplant diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transplant diagnostics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the transplant diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transplant diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant diagnostics market.

The report delves into the competitive landscape of the global transplant diagnostics market. Key players operating in the global transplant diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transplant diagnostics market profiled in this report.

Key Questions Answered in Global transplant diagnostics Market Report
• What is the sales/revenue generated by transplant diagnostics across all regions during the forecast period?
• What are the opportunities in the global transplant diagnostics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Transplant Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global transplant diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transplant diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transplant diagnostics market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transplant Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Screening, 2017–2031
6.3.1. Pre-transplant Diagnostics
6.3.2. Post-transplant Diagnostics
6.4. Market Attractiveness, by Screening
7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technique, 2017–2031
7.3.1. Molecular Assay
7.3.2. Non-molecular Assay
7.3.3. 7.4 Market Attractiveness, by Technique
8. Global Transplant Diagnostics Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Solid Organ Transplantation
8.3.1.1. Kidney
8.3.1.2. Liver
8.3.1.3. Heart
8.3.1.4. Lungs
8.3.1.5. Pancreas
8.3.1.6. Small Bowel
8.3.2. Stem Cell Transplantation
8.4. Market Attractiveness, by Application
9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Products & Services, 2017–2031
9.3.1. Reagents & Consumables
9.3.2. Instruments
9.3.3. Software & Services
9.4. Market Attractiveness, by Products & Services
10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals & Transplant Centers
10.3.2. Research Laboratories
10.3.3. Others
10.4. Market Attractiveness, by End-user
11. Global Transplant Diagnostics Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Transplant Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Screening, 2017–2031
12.2.1. Pre-transplant Diagnostics
12.2.2. Post-transplant Diagnostics
12.3. Market Attractiveness, by Screening
12.4. Market Value Forecast, by Technique, 2017–2031
12.4.1. Molecular Assay
12.4.2. Non-molecular Assay
12.5. Market Attractiveness, by Technique
12.6. Market Value Forecast, by Application, 2017–2031
12.6.1. Solid Organ Transplantation
12.6.1.1. Kidney
12.6.1.2. Liver
12.6.1.3. Heart
12.6.1.4. Lungs
12.6.1.5. Pancreas
12.6.1.6. Small Bowel
12.6.2. Stem Cell Transplantation
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by Products & Services, 2017–2031
12.8.1. Reagents & Consumables
12.8.2. Instruments
12.8.3. Software & Services
12.9. Market Attractiveness, by Products & Services
12.10. Market Value Forecast, by End-user, 2017–2031
12.10.1. Hospitals & Transplant Centers
12.10.2. Research Laboratories
12.10.3. Others
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Screening
12.13.2. By Technique
12.13.3. By Application
12.13.4. By Products & Services
12.13.5. By End-user
12.13.6. By Country
13. Europe Transplant Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Screening, 2017–2031
13.2.1. Pre-transplant Diagnostics
13.2.2. Post-transplant Diagnostics
13.3. Market Attractiveness, by Screening
13.4. Market Value Forecast, by Technique, 2017–2031
13.4.1. Molecular Assay
13.4.2. Non-molecular Assay
13.5. Market Attractiveness, by Technique
13.6. Market Value Forecast, by Application, 2017–2031
13.6.1. Solid Organ Transplantation
13.6.1.1. Kidney
13.6.1.2. Liver
13.6.1.3. Heart
13.6.1.4. Lungs
13.6.1.5. Pancreas
13.6.1.6. Small Bowel
13.6.2. Stem Cell Transplantation
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by Products & Services, 2017–2031
13.8.1. Reagents & Consumables
13.8.2. Instruments
13.8.3. Software & Services
13.9. Market Attractiveness, by Products & Services
13.10. Market Value Forecast, by End-user, 2017–2031
13.10.1. Hospitals & Transplant Centers
13.10.2. Research Laboratories
13.10.3. Others
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Screening
13.13.2. By Technique
13.13.3. By Application
13.13.4. By Products & Services
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Screening, 2017–2031
14.2.1. Pre-transplant Diagnostics
14.2.2. Post-transplant Diagnostics
14.3. Market Attractiveness, by Screening
14.4. Market Value Forecast, by Technique, 2017–2031
14.4.1. Molecular Assay
14.4.2. Non-molecular Assay
14.5. Market Attractiveness, by Technique
14.6. Market Value Forecast, by Application, 2017–2031
14.6.1. Solid Organ Transplantation
14.6.1.1. Kidney
14.6.1.2. Liver
14.6.1.3. Heart
14.6.1.4. Lungs
14.6.1.5. Pancreas
14.6.1.6. Small Bowel
14.6.2. Stem Cell Transplantation
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by Products & Services, 2017–2031
14.8.1. Reagents & Consumables
14.8.2. Instruments
14.8.3. Software & Services
14.9. Market Attractiveness, by Products & Services
14.10. Market Value Forecast, by End-user, 2017–2031
14.10.1. Hospitals & Transplant Centers
14.10.2. Research Laboratories
14.10.3. Others
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Screening
14.13.2. By Technique
14.13.3. By Application
14.13.4. By Products & Services
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Transplant Diagnostics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Screening, 2017–2031
15.2.1. Pre-transplant Diagnostics
15.2.2. Post-transplant Diagnostics
15.3. Market Attractiveness, by Screening
15.4. Market Value Forecast, by Technique, 2017–2031
15.4.1. Molecular Assay
15.4.2. Non-molecular Assay
15.5. Market Attractiveness, by Technique
15.6. Market Value Forecast, by Application, 2017–2031
15.6.1. Solid Organ Transplantation
15.6.1.1. Kidney
15.6.1.2. Liver
15.6.1.3. Heart
15.6.1.4. Lungs
15.6.1.5. Pancreas
15.6.1.6. Small Bowel
15.6.2. Stem Cell Transplantation
15.7. Stem Cell Transplantation Market Attractiveness, by Application
15.8. Market Value Forecast, by Products & Services, 2017–2031
15.8.1. Reagents & Consumables
15.8.2. Instruments
15.8.3. Software & Services
15.9. Market Attractiveness, by Products & Services
15.10. Market Value Forecast, by End-user, 2017–2031
15.10.1. Hospitals & Transplant Centers
15.10.2. Research Laboratories
15.10.3. Others
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Screening
15.13.2. By Technique
15.13.3. By Application
15.13.4. By Products & Services
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Screening, 2017–2031
16.2.1. Pre-transplant Diagnostics
16.2.2. Post-transplant Diagnostics
16.3. Market Attractiveness, by Screening
16.4. Market Value Forecast, by Technique, 2017–2031
16.4.1. Molecular Assay
16.4.2. Non-molecular Assay
16.5. Market Attractiveness, by Technique
16.6. Market Value Forecast, by Application, 2017–2031
16.6.1. Solid Organ Transplantation
16.6.1.1. Kidney
16.6.1.2. Liver
16.6.1.3. Heart
16.6.1.4. Lungs
16.6.1.5. Pancreas
16.6.1.6. Small Bowel
16.6.2. Stem Cell Transplantation
16.7. Market Attractiveness, by Application
16.8. Market Value Forecast, by Products & Services, 2017–2031
16.8.1. Reagents & Consumables
16.8.2. Instruments
16.8.3. Software & Services
16.9. Market Attractiveness, by Products & Services
16.10. Market Value Forecast, by End-user, 2017–2031
16.10.1. Hospitals & Transplant Centers
16.10.2. Research Laboratories
16.10.3. Others
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Screening
16.13.2. By Technique
16.13.3. By Application
16.13.4. By Products & Services
16.13.5. By End-user
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. Bio-Rad laboratories, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Qiagen N.V.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. F. Hoffmann-La Roche AG
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Thermo Fisher Scientific, Inc.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Becton, Dickinson and Company
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Ortho Clinical Diagnostics
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Immucor, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Illumina, Inc.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Siemens Healthineers (Siemens AG)
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Agilent Technologies
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview